Matrixx Initiatives, Inc., et al. v. James Siracusano and NECA-IBEW Pension Fund

Published on:
August 27, 2010

SIFMA has submitted an Amicus “Friend of the Court” Brief

Court:

U.S. Supreme Court

Amicus Issue:

Whether a plaintiff can state a claim under § 10(b) of the Securities Exchange Act and SEC Rule 10b-5 based on a pharmaceutical company’s nondisclosure of adverse event reports even though the reports are not alleged to be statistically significant.

Counsel of Record:

Dewey & LeBoeuf LLP

1101 New York Avenue, NW

Washington, DC 20005

Lyle Roberts

Jonathan E. Richman

N. Noelle Francis

Other Amici on SIFMA’s Brief:

U.S. Chamber of Commerce

Details

Download

More Content

  • Letters
    Oct 22, 2026

    Treasury/IRS Notice 2026-49: Guidance on Section 324 of the SECURE 2.0 Act with Respect to Rollovers

    SIFMA supports modernizing retirement plan rollovers through standardized electronic processes, fraud safeguards and appropriate implementation timelines.
  • Amicus Briefs
    Oct 21, 2026

    In re USD LIBOR Litigation

  • Letters
    Oct 20, 2026

    SEC’s Proposed Rule Regulation Crypto Assets

    SIFMA and SIFMA AMG provide recommendations to the SEC on its proposed crypto asset regulation, addressing regulatory clarity, implementation and investor protection.

Get the latest trends, stats, and research on financial markets and securities.